phosphorylcholine has been researched along with Abdominal Pain in 3 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Abdominal Pain: Sensation of discomfort, distress, or agony in the abdominal region.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral perifosine was tolerable up to 600mg/week in cancer patients when administered with meal and prophylactic antiemetics." | 2.75 | First-time-in-man and pharmacokinetic study of weekly oral perifosine in patients with solid tumours. ( Berdel, W; Engel, J; Hanauske, AR; Mross, K; Sindermann, H; Unger, C, 2010) |
| "Miltefosine is an oral medication with anti-leishmania activity and may increase the cure rates and improve compliance." | 2.75 | Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial. ( Ampuero, J; Carvalho, EM; Guimarães, LH; Machado, PR; Penna, G; Rocha, AT; Schriefer, A; Sousa, RS; Talhari, A; Villasboas, L, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botschuijver, S | 1 |
| van Diest, SA | 1 |
| van Thiel, IAM | 1 |
| Saia, RS | 1 |
| Strik, AS | 1 |
| Yu, Z | 1 |
| Maria-Ferreira, D | 1 |
| Welting, O | 1 |
| Keszthelyi, D | 1 |
| Jennings, G | 1 |
| Heinsbroek, SEM | 1 |
| Elferink, RPO | 1 |
| Schuren, FHJ | 1 |
| de Jonge, WJ | 1 |
| van den Wijngaard, RM | 1 |
| Unger, C | 1 |
| Berdel, W | 1 |
| Hanauske, AR | 1 |
| Sindermann, H | 1 |
| Engel, J | 1 |
| Mross, K | 1 |
| Machado, PR | 1 |
| Ampuero, J | 1 |
| Guimarães, LH | 1 |
| Villasboas, L | 1 |
| Rocha, AT | 1 |
| Schriefer, A | 1 |
| Sousa, RS | 1 |
| Talhari, A | 1 |
| Penna, G | 1 |
| Carvalho, EM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Trial to Assess Efficacy and Safety of Orally Administered Miltefosine in Brazilian Patients With Cutaneous Leishmaniasis Compared to the Standard Care as Active Control[NCT00600548] | Phase 2 | 180 participants (Actual) | Interventional | 2007-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for phosphorylcholine and Abdominal Pain
| Article | Year |
|---|---|
First-time-in-man and pharmacokinetic study of weekly oral perifosine in patients with solid tumours.
Topics: Abdominal Pain; Administration, Oral; Antiemetics; Antineoplastic Agents; Diarrhea; Dose-Response Re | 2010 |
Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.
Topics: Abdominal Pain; Administration, Oral; Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Brazi | 2010 |
1 other study available for phosphorylcholine and Abdominal Pain
| Article | Year |
|---|---|
Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms.
Topics: Abdominal Pain; Animals; Antifungal Agents; Female; Fungi; Gastrointestinal Microbiome; Humans; Irri | 2019 |